Task: Answer the MCQ question.
Query: Which drug exhibits a 2.216% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) Cc1ccc(CNc2ccc(N3CCOCC3)cc2)cc1
b) O=C(CN1CCCC1)Nc1cc(C(F)(F)F)ccc1Cl
c) CCC(=O)Nc1nc(C)c(-c2csc(Nc3cccc(C(=O)O)c3)n2)s1
Answer: b. O=C(CN1CCCC1)Nc1cc(C(F)(F)F)ccc1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CN1CCCC1)Nc1cc(C(F)(F)F)ccc1Cl
O=C(CN1CCCC1)Nc1cc(C(F)(F)F)ccc1Cl
N-[2-chloro-5-(trifluoromethyl)phenyl]-2-pyrrolidin-1-ylacetamide